BARBARA STOLL to Bronchopulmonary Dysplasia
This is a "connection" page, showing publications BARBARA STOLL has written about Bronchopulmonary Dysplasia.
Connection Strength
0.477
-
Association between Use of Prophylactic Indomethacin and the Risk for Bronchopulmonary Dysplasia in Extremely Preterm Infants. J Pediatr. 2017 07; 186:34-40.e2.
Score: 0.116
-
Blood Cytokine Profiles Associated with Distinct Patterns of Bronchopulmonary Dysplasia among Extremely Low Birth Weight Infants. J Pediatr. 2016 07; 174:45-51.e5.
Score: 0.109
-
Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. JAMA. 2015 Sep 08; 314(10):1039-51.
Score: 0.105
-
Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. Am J Respir Crit Care Med. 2011 Jun 15; 183(12):1715-22.
Score: 0.076
-
Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018. JAMA. 2022 01 18; 327(3):248-263.
Score: 0.041
-
Mortality and pulmonary outcomes of extremely preterm infants exposed to antenatal corticosteroids. Am J Obstet Gynecol. 2018 01; 218(1):130.e1-130.e13.
Score: 0.030